Student or educator? Sign up with your school email and get 6 months of Pro free.
CoChat

The DOI matches its Crossref record; 138 of the 138 references it cites were found in a registry or an index; 75 of the 149 sources its claims cite were checked for support.

Persistent physical symptoms: definition, genesis, and management

Open access

Abstract

Persistent physical symptoms (synonymous with persistent somatic symptoms) is an umbrella term for distressing somatic complaints that last several months or more, regardless of their cause. These symptoms are associated with substantial disability and represent a major burden for patients, health-care professionals, and society. Persistent physical symptoms can follow infections, injuries, medical diseases, stressful life events, or arise de novo. As symptoms persist, their link to clearly identifiable pathophysiology often weakens, making diagnosis and treatment challenging. Multiple biological and psychosocial risk factors and mechanisms contribute to the persistence of somatic symptoms, including persistent inflammation; epigenetic profiles; immune, metabolic and microbiome dysregulation; early adverse life experiences; depression; illness-related anxiety; dysfunctional symptom expectations; symptom focusing; symptom learning; and avoidance behaviours, with many factors being common across symptoms and diagnoses. Basic care consists of addressing underlying pathophysiology and using person-centred communication techniques with validation, appropriate reassurance, and biopsychosocial explanation. If basic care is insufficient, targeted psychological and pharmacological interventions can be beneficial. A better understanding of the multifactorial persistence of somatic symptoms should lead to more specific, personalised, and mechanism-based treatment, and a reduction in the stigma patients commonly face.

Overview

CoChat Summary

TL;DR

Persistent physical symptoms are distressing somatic complaints lasting several months or more regardless of cause, common across somatic, functional, and mental disorders, and best understood through multifactorial biopsychosocial mechanisms. Management starts with diagnosis-specific treatment plus person-centred communication, with targeted psychological and pharmacological options when basic care is insufficient.

Key findings

  • Persistent physical symptoms are defined as distressing somatic complaints present on most days for at least several months, regardless of cause. They account for up to 50% of all consultations in Western primary care; approximately a third cannot be attributed to a recognised disease, and prevalence is also high in chronic diseases (e.g., 70% of patients with chronic kidney disease have persistent fatigue, 63% with coronary heart disease have persistent arm, leg, or joint pain, and 31% with ulcerative colitis in remission have persistent gastrointestinal symptoms).
  • Genesis is multifactorial and transdiagnostic. Predisposing factors include female sex or gender, lower socioeconomic status, lower education, chronic medical conditions, previous somatic symptom burden, sleep disturbance, elevated body mass index, genetic or epigenetic profiles, early adverse life experiences, depression, and anxiety. Maintaining factors include persistent inflammation; immune, metabolic, and microbiome dysregulation; symptom focusing; catastrophising; dysfunctional expectations; avoidance behaviours; and predictive coding processes in which strong priors can sustain symptoms even when ascending sensory input is diminished.
  • Basic care consists of diagnosis-specific treatment of underlying pathophysiology plus person-centred communication with validation, appropriate reassurance, and a biopsychosocial explanation. If basic care is insufficient, targeted psychological and pharmacological interventions can be beneficial: a 2023 meta-analysis found psychological interventions had a small, statistically significant effect on reducing somatic symptoms; CBT trials showed small-to-moderate positive effects; short-term psychodynamic psychotherapy had medium effect sizes in a range of medical conditions and a large effect size for functional somatic symptoms; antidepressant evidence is limited, with very low-quality evidence for somatoform disorders, though some antidepressants are effective for specific symptoms and comorbid depressive or anxiety disorders.

Methods

  • This is a narrative Review. The authors searched PubMed, Scopus, and PsycInfo for “persistent somatic symptom*” or “persistent physical symptom*” in titles or abstracts, from database inception to Jan 27, 2024, with no filters or language restrictions and without excluding grey literature. The search was combined with keywords related to individual Review topics, and related terms were also sought in the same databases and in reference lists of journal articles and book chapters.
  • For the final reference list, articles most relevant to the Review sections were selected, prioritising systematic reviews and meta-analyses, randomised controlled trials, and prospective studies over cross-sectional studies and other publication types. Disagreements over inclusion were resolved by discussion between BL, AT, and PH.
  • The Review presents a conceptual working model of risk factors and mechanisms, a predictive coding model of symptom perception, treatment principles, a case scenario, and research needs.

Limitations

  • The paper states that the Review is largely based on the current state of knowledge on persistent physical symptoms, where the aetiopathogenesis is not yet fully understood. It also states that the list of exemplary risk factors and mechanisms is clearly incomplete, and not every risk factor or mechanism has been studied in all symptoms and conditions; more prospective studies are needed, including in conditions with poorly understood pathophysiology such as post-COVID-19 condition.
  • Evident from the text: as a narrative Review, it does not conduct a formal systematic quality appraisal or quantitative synthesis, and treatment evidence is described as still fragmentary, with insufficient availability and effectiveness of treatment and little knowledge among treating physicians.

Model-written summary. Check it against the paper before relying on it.

Integrity signals

Registry

Crossref · 10.1016/s0140-6736(24)00623-8

Cites

138 of 138 references verified0 citation errors · 0 not checkable

Statistics

Nothing to recompute.

Figures

Figure 1 Conceptual working model of risk factors and mechanisms currently under discussion for the persistence of somatic symptoms
Figure 1 Conceptual working model of risk factors and mechanisms currently under discussion for the persistence of somatic symptomsFrom the PDF
Figure 2 Illustration of the predictive coding model in symptom perception
Figure 2 Illustration of the predictive coding model in symptom perceptionFrom the PDF

Verification

Claims the paper makes

48 Valid · 5 Not valid · 24 Not checked · 23 Own results and interpretations

36 more claims · 21 with their cited sources checked

Create a free account to see all 100 claims and to verify the 1 reference still open.

See all claims — free account
  • It may state two separate claims as one. 38
  • The quote only partly states this claim. 6
  • Probably not a substantial claim. 30

Create a free account to see these claims.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Citations

Cites

Show all 136 references

Cited by

See all 280

Metadata

Authors
Löwe, B., Toussaint, A., Rosmalen, J. G. M., Huang, W.-L., Burton, C., Weigel, A., Levenson, J. L., & Henningsen, P.
Affiliations
  • University Medical Center Hamburg-Eppendorf (DE)
  • University Medical Center Groningen (NL)
  • National Taiwan University (TW)
  • University of Sheffield (GB)
  • Virginia Commonwealth University (US)
  • Technical University of Munich (DE)
Corresponding author
Löwe, Bernd
Venue
The Lancet
Publisher
Elsevier BV
Published
2024-06
Volume
403
Issue
10444
Pages
2649-2662
ISSN
  • 0099-5355 (ISSN-L)
  • 0140-6736
OpenAlex
W4399611661
Cited by
280
References
136
Citations by year
2026: 122 · 2025: 123 · 2024: 35
FWCI
22.31
Type
journal article
Language
en
Open access
Licence
Locations
  • The Lancet (publishedVersion, cc-by)
  • PubMed (publishedVersion)
  • White Rose Research Online (University of Leeds, The University of Sheffield, University of York) (acceptedVersion)
  • mediaTUM – the media and publications repository of the Technical University Munich (Technical University Munich) (submittedVersion)
  • University of Groningen research database (University of Groningen / Centre for Information Technology) (submittedVersion, cc-by)
Funders
Deutsche Forschungsgemeinschaft (RU 5211)
Topics
  • Health Sciences › Medicine › Psychiatry and Mental health › Psychosomatic Disorders and Their Treatments
  • Health Sciences › Medicine › Psychiatry and Mental health › Fibromyalgia and Chronic Fatigue Syndrome Research
  • Social Sciences › Arts and Humanities › History and Philosophy of Science › Medicine, History, and Philosophy
Keywords
persistent physical symptoms, symptom persistence, psychosomatic disorders, chronic pain, disability, chronic inflammation, epigenetics, life events, depression, health anxiety, symptom expectations, avoidance behavior, person-centred communication, biopsychosocial model, stigma, psychological intervention, pharmacotherapy
MeSH terms
Medically Unexplained Symptoms, Humans, Risk Factors, Somatoform Disorders

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

The claim verdicts this report counts are experimental: their accuracy is not yet measured.

A language model drew the claims from the paper on 2026-09-28, under version 3 of the claim definition (prompt extract-v3).

A second model labelled each claim on 2026-09-28 (model jev-1.13-20260917, definition revision gold-guideline-v0.2).

Cited sources are checked with a language model’s help (gpt-6-sol).

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Persistent physical symptoms: definition, genesis, and management. https://app.cochat.ai/papers/10.1016/s0140-6736(24)00623-8
The paper
Löwe, B., Toussaint, A., Rosmalen, J. G. M., Huang, W.-L., Burton, C., Weigel, A., Levenson, J. L., & Henningsen, P. (2024). Persistent physical symptoms: definition, genesis, and management. The Lancet. https://doi.org/10.1016/s0140-6736(24)00623-8

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.